DIN 02495058 — XOSPATA 40 MG
XOSPATA is a tablet of Gilteritinib marketed by ASTELLAS PHARMA CANADA INC. The full Gilteritinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02495058
- Brand name
- XOSPATA
- Active ingredient
- Gilteritinib
- Strength
- 40 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ASTELLAS PHARMA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent - FLT3 tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.